A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell Cancer

Clinical trial NCT01004250 · COMPLETED

Trial details

NCT number: NCT01004250
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2009-10-01
Primary completion: 2012-11-01
Enrollment: 109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.